Preexisting TP53 -Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients with High-grade Ovarian Cancer Treated with Rucaparib

Tanya T. Kwan, Amit M. Oza, Anna V. Tinker, Isabelle Ray-Coquard, Ana Oaknin, Carol Aghajanian, Domenica Lorusso, Nicoletta Colombo, Andrew Dean, Johanne Weberpals, Eric Severson, Lan Thanh Vo, Sandra Goble, Lara Maloney, Thomas Harding, Scott H. Kaufmann, Jonathan A. Ledermann, Robert L. Coleman, Iain A. McNeish, Kevin K. LinElizabeth M. Swisher

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Preexisting TP53 -Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients with High-grade Ovarian Cancer Treated with Rucaparib'. Together they form a unique fingerprint.

Medicine & Life Sciences